MonoAbsorb Omega 1300
MonoAbsorb Omega 1300 contains natural enzymatically enhanced MaxSimil® monoglyceride fish oil that has a three times greater EPA/DHA absorption rate than an equivalent dose of ethyl ester fish oil.
This IFOS five-star certified fish oil outperforms other fish oil supplements through MaxSimil patented lipid absorption enhancement technology (PLATform).
- Positively Affects the Production of Arachidonic Acid-Derived Eicosanoids*
- Supports Cardiovascular Health*
- Supports Healthy Mental Functioning*
- Supports Healthy Glucose and Insulin Metabolism* By Supplying the Precursors EPA and DHA, Helps the Body Generate Specialized Proresolving Lipid Mediators, Such as Resolvins and Protectins
Serving Size: 1 Softgel
Servings Per Container: 60
- Calories 10
- Total Fat 1 g 1%†
- MaxSimil® Fish Oil Concentrate 1.3 g **
- Total Omega-3 Fatty Acids 860 mg **
- EPA (eicosapentaenoic acid) 600 mg **
- DHA (docosahexaenoic acid) 260 mg **
- DPA (docosapentaenoic acid) 25 mg **
† Percent Daily Values are based on a 2,000 calorie diet.
** Daily Value not established.
Other Ingredients: Softgel (fish gelatin, vegetable glycerin, and purified water), GRAS enteric coating (ethylcellulose, sodium alginate, purified water, medium-chain triglycerides, oleic acid, vegetable stearic acid, and ammonium hydroxide), and mixed natural tocopherols.
Contains: Fish (anchovy and/or sardine [sources of fish oil], tilapia and/or pangasius [sources of fish gelatin]).
Formulated To Exclude: Wheat, gluten, corn, yeast, soy protein, dairy products, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.
Take one softgel daily, or use as directed by your healthcare professional.
Consult your healthcare professional prior to use.
Individuals taking blood thinners or other medication should discuss potential interactions with their healthcare professional.
Do not use if tamper seal is damaged.
STORAGE: Keep tightly closed in a cool, dry place out of reach of children.
Our Review*
Omega 3 fatty acids have demonstrated efficacy for reducing chronic inflammation observed in autoimmune disorders (1) and improving quality of life and reducing relapse rate in people with multiple sclerosis.(2) References 1. Parolini C. Marine n-3 polyunsaturated fatty acids: Efficacy on inflammatory-based disorders. Life Sci. 2020;263:118591. 2. AlAmmar WA, Albeesh FH, Ibrahim LM, Algindan YY, Yamani LZ, Khattab RY. Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review. Nutr Neurosci. 2021;24(7):569-579.
